Removal of selected pharmaceuticals by chlorination, coagulation- sedimentation and powdered activated carbon treatment

Water Science and Technology

Volumn 58, Issue 5, 2008, Pages 1129-1135

  Simazaki, D ^a   Fujiwara, J ^b   Manabe, S ^c   Matsuda, M ^d   Asami, M ^a   Kunikane, S ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b Hanshin Water Supply Authority   (Japan)

^c Kawasaki Waterworks Bureau   (Japan)

^d Shimonoseki City Hospital   (Japan)

Author keywords

Chlorination; Coagulation; Drinking water treatment; Pharmaceutical; Powdered activated carbon

Indexed keywords

ACTIVATED CARBON; CLOFIBRIC ACID; DICLOFENAC; DRINKING WATER; FENOPROFEN; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; PROPYPHENAZONE;

ADSORPTION; ARTICLE; CHLORINATION; DEGRADATION; DRUG STRUCTURE; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; SEDIMENTATION; WATER TREATMENT;

ANTIPYRINE; CHARCOAL; CLOFIBRIC ACID; DICLOFENAC; FENOPROFEN; GEMFIBROZIL; HALOGENATION; IBUPROFEN; INDOMETHACIN; KETOPROFEN; NAPROXEN; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER SUPPLY;

EID: 55349132361     PISSN: 02731223     EISSN: None     Source Type: Book Series    
DOI: 10.2166/wst.2008.472     Document Type: Article

References (13)

1. Bruchei, A., Hochereau, C., Picard, C., Decottignies, V., Rodrigues, J. M. & Janex-Habibi, M. L. 2005 Analysis of Drugs and Personal Care Products in French Source and Drinking Waters: The Analytical Challenge and Examples of Application. Water Sci. Technol. 52(8), 53-61.
2. Hans-Rudolf, B., Markus, D. M. & Norbert, T. 1998 Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 32(1), 188-192.
3. Huber, M. M., Canonica, S., Park, G.-Y. & Gunten, U. 2003 Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37(A2), 1016-1024.
4. Jones, O. A. H., Voulvoulis, N. & Lester, J. N. 2001 Human pharmaceuticals in the aquatic environment a review. Environ. Technol. (Lett) 22(12), 1383-1394.
5. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. & Buxton, H. T. 2002 Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36, 1202-1211.
6. Nghiem, L. D., Schafer, A. I. & Elimelech, M. 2005 Pharmaceutical retention mechanisms by nanofiltration membranes. Environ. Sci. Technol. 39, 7698-7705.
7. Richardson, M. L. & Bowron, J. M. 1985 The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 37(1), 1-12.
8. Urase, T. & Kikuta, T. 2005 Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res. 39(7), 1289-1300.
9. Ternes, T. A. 1988 Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32(11), 3245-3260.
10. Ternes, T. A., Meisenheimer, M., Mcdowell, D., Sacher, F., Brauch, H.-J., Haist-Gulde, B., Preuss, G., Wilme, U. & Zulei-Seibert, N. 2002 Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36(A1), 3855-3863.
11. U.S. EPA2000 KOWWIN v1.67 (included in EPI Suite v3.20 (2007)) http://www.epa.gov/opptintr/exposure/pubs/episuite.htm
12. Westerhoff, P., Yoon, Y., Snyder, S. & Wert, E. 2005 Fate of endocrine-disrupter, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39(17), 6649-6663.
13. Xu, P., Drewes, J. E., Bellona, C., Amy, G., Kim, T.-U., Adam, M. & Heberer, T. 2005 Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane application. Water Environ. Res. 77(1), 40-48.